Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer

This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.

Inclusion Criteria:

• Subjects with advanced prostate cancer who are eligible to receive sipuleucel-T in accordance with FDA approved labeling of sipuleucel-T
• Subjects must understand and sign an informed consent form

Exclusion Criteria:

• Subjects who are not eligible to receive sipuleucel-T